2022. Serum Lipoprotein Ratios as Markers for Insulin Resistance Among Non-Diabetic Acute Coronary Syndrome Patients with Impaired Fasting Glucose. Iraqi Journal of Medical Sciences. 20, 2 (Nov. 2022).